CompletedNCT05869708
PRISM neurofeedback for anhedonia and major depression
About this title
Read the official source — NCT05869708Device studyAges 22–65United States
Understand this study
Who was this study for?
Listed age limits: 22 years to 65 years.
- Listed locations
- BelmontSee all locations and recruitment
Study information
Study start dateStarted: July 1, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 19
- Sponsor
- GrayMatters Health Ltd.
- Sponsor type
- Other organization
- Study type
- Device
- Intervention type
- Device
- Locations
- United States
- Age range
- From 22 Years to 65 Years
- Official registry ID
- NCT05869708
- Official title
Show the full official title
Personalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Belmont
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is GrayMatters Health Ltd.
Who was this study for?
Listed age limits: 22 years to 65 years.
